Bristol-Myers Squibb Company (NYSE: BMY)
| Pre-Market | Intra-Day | After-Hours |
|---|---|---|
| 64.65 (-0.21 / -0.32%) | 65.30 (+0.44 / +0.68%) | 65.39 (+0.09 / +0.14%) |
| 31-Jul 09:18 | 31-Jul 15:59 | 31-Jul 18:56 |
Sector: Healthcare || Industry: Drug Manufacturers - General
| Previous Close | 64.86 | Year Low | 42.52 |
| Open | 65.14 | Year High | 65.66 |
| Day Low | 63.53 | Price Avg 50 | 57.98 |
| Day High | 65.66 | Price Avg 200 | 55.46 |
| Volume | 10.18 M | Market Cap | 133.35 B |
News
Analysis
| Symbol | 1D | 5D | 1M | 3M | 6M | 1Y |
|---|---|---|---|---|---|---|
| BMY | 0.68 | 5.42 | 13.33 | 7.77 | 18.62 | 50.77 |
Earnings
| Date | Time | Symbol | company_name | Period | Metric | Estimate | Actual | Surprise | YrAgo | Growth | sector_industry |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 07/30/2026 | BMO | BMY | Bristol-Myers Squibb | Q2 2026 | EPS | 1.59 | 2.04 | 28.30 | 1.46 | 39.70 | |
| 07/30/2026 | BMO | BMY | Bristol-Myers Squibb | Q2 2026 | REV | 11.75 B | 12.97 B | 10.45 | 12.30 B | 5.47 | |
| 04/30/2026 | BMO | BMY | Bristol-Myers Squibb | Q1 2026 | EPS | 1.42 | 1.58 | 11.27 | 1.80 | -12.20 | |
| 04/30/2026 | BMO | BMY | Bristol-Myers Squibb | Q1 2026 | REV | 10.91 B | 11.49 B | 5.31 | 11.20 B | 2.57 | |
| 02/05/2026 | BMO | BMY | Bristol-Myers Squibb | Q4 2025 | EPS | 1.12 | 1.26 | 12.50 | 1.67 | -24.60 | |
| 02/05/2026 | BMO | BMY | Bristol-Myers Squibb | Q4 2025 | REV | 12.28 B | 12.50 B | 1.80 | 12.34 B | 1.31 | |
| 10/30/2025 | BMO | BMY | Bristol-Myers Squibb | Q3 2025 | EPS | 1.51 | 1.63 | 7.95 | 1.80 | -9.40 | |
| 10/30/2025 | BMO | BMY | Bristol-Myers Squibb | Q3 2025 | REV | 11.81 B | 12.22 B | 3.46 | 11.89 B | 2.77 |
Outlooks
| Date | Time | Symbol | Company | Period | Metric | Estimate | Outlook | Previous | Catalyst | list_link | eps_est | rev_est | cur_midpoint | pre_midpoint | Growth * | yrago_growth | pre_growth | company_sector | company_industry | ref_id | chart_code | history_code | sector_industry |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 07/30/2026 | 06:59 AM | BMY | Bristol-Myers Squibb | FY 2026 | EPS | $6.34 | $6.75 ~ $7.00 | $6.05 ~ $6.35 | 0.00 | 6.88 | 6.20 | 8.52 | 10.97 | 48,280 | |||||||||
| 07/30/2026 | 06:59 AM | BMY | Bristol-Myers Squibb | FY 2026 | REV | $47.47 B | $49.00 B ~ $50.00 B | $46.00 B ~ $47.50 B | 0.00 | 49,500.00 | 46,750.00 | 4.27 | 5.88 | 48,280 | |||||||||
| 02/05/2026 | 06:59 AM | BMY | Bristol-Myers Squibb | FY 2026 | EPS | $6.02 | $6.05 ~ $6.35 | 0.00 | 6.20 | 2.99 | 42,947 | ||||||||||||
| 02/05/2026 | 06:59 AM | BMY | Bristol-Myers Squibb | FY 2026 | REV | $44.16 B | $46.00 B ~ $47.50 B | 0.00 | 46,750.00 | 5.87 | 42,947 |
Ratings
| Date | Symbol | Analyst Firm | Rating Current | Rating Previous | Analyst Action |
|---|---|---|---|---|---|
| 04/09/2026 | BMY | B of A Securities | Buy | Buy | Maintain |
| 04/08/2026 | BMY | Guggenheim | Buy | Buy | Maintain |
| 04/08/2026 | BMY | Cantor Fitzgerald | Neutral | Neutral | Maintain |
| 03/17/2026 | BMY | HSBC | Hold | Hold | Maintain |
| 02/23/2026 | BMY | Piper Sandler | Overweight | Overweight | Maintain |
| 02/06/2026 | BMY | Wells Fargo | Equal Weight | Equal Weight | Maintain |
| 02/06/2026 | BMY | Guggenheim | Buy | Buy | Maintain |
| 02/06/2026 | BMY | Citigroup | Neutral | Neutral | Maintain |
| 01/28/2026 | BMY | Piper Sandler | Overweight | Overweight | Maintain |
| 01/27/2026 | BMY | Citigroup | Neutral | Neutral | Maintain |
Dividends
| Date | Symbol | Company | Type | Value | Yield | Record Date | Exch Date | Pay Date | Notes |
|---|---|---|---|---|---|---|---|---|---|
| 03/02/2026 | BMY | Bristol-Myers Squibb | Quarterly | 0.63 | 0.04 | 04/02/2026 | 04/02/2026 | 05/01/2026 | Increased |
| 12/10/2025 | BMY | Bristol-Myers Squibb | Quarterly | 0.63 | 0.05 | 01/02/2026 | 01/02/2026 | 02/02/2026 | Increased |
| 09/17/2025 | BMY | Bristol-Myers Squibb | Quarterly | 0.62 | 0.05 | 10/03/2025 | 10/03/2025 | 11/03/2025 | Increased |
Sign-Up to see the full list of CATALYSTS in the Calendars
